AAAAAA
Results: 1-25/47
Authors:
HAKKAARTVANROIJEN L
BECKERS A
STEVENAERT A
RUTTEN FFH
Citation: L. Hakkaartvanroijen et al., THE BURDEN OF ILLNESS OF HYPOPITUITARY ADULTS WITH GROWTH-HORMONE DEFICIENCY, PharmacoEconomics, 14(4), 1998, pp. 395-403
Authors:
BUSSCHBACH JJV
BROUWER WBF
VANDERDONK A
PASSCHIER J
RUTTEN FFH
Citation: Jjv. Busschbach et al., AN OUTLINE FOR A COST-EFFECTIVENESS ANALYSIS OF A DRUG FOR PATIENTS WITH ALZHEIMERS-DISEASE, PharmacoEconomics, 13(1), 1998, pp. 21-34
Authors:
AL MJ
VANHOUT BA
MICHEL BC
RUTTEN FFH
Citation: Mj. Al et al., SAMPLE-SIZE CALCULATION IN ECONOMIC EVALUATIONS, Health economics, 7(4), 1998, pp. 327-335
Authors:
VANDERWIJK P
BOUMA J
VANWAAS MAJ
VANOORT RP
RUTTEN FFH
Citation: P. Vanderwijk et al., THE COST OF DENTAL IMPLANTS AS COMPARED TO THAT OF CONVENTIONAL STRATEGIES, The International journal of oral and maxillofacial implants, 13(4), 1998, pp. 546-553
Authors:
BROUWER WBF
KOOPMANSCHAP MA
RUTTEN FFH
Citation: Wbf. Brouwer et al., PATIENT AND INFORMAL CAREGIVER TIME IN COST-EFFECTIVENESS ANALYSIS - A RESPONSE TO THE RECOMMENDATIONS OF THE WASHINGTON PANEL, International journal of technology assessment in health care, 14(3), 1998, pp. 505-513
Authors:
VANENCKEVORT PJ
TENVERGERT EM
BONSEL GJ
GEERTSMA A
VANDERBIJ W
DEBOER WJ
KOOPMANSCHAP MA
AL MJ
RUTTEN FFH
Citation: Pj. Vanenckevort et al., TECHNOLOGY-ASSESSMENT OF THE DUTCH LUNG TRANSPLANTATION PROGRAM, International journal of technology assessment in health care, 14(2), 1998, pp. 344-356
Authors:
ADANG EMM
ENGEL GL
RUTTEN FFH
GEERDES BP
BAETEN CGMI
Citation: Emm. Adang et al., COST-EFFECTIVENESS OF DYNAMIC GRACILOPLASTY IN PATIENTS WITH FECAL INCONTINENCE, Diseases of the colon & rectum, 41(6), 1998, pp. 725-733
Authors:
UYLDEGROOT CA
LOWENBERG B
VELLENGA E
SUCIU S
WILLEMZE R
RUTTEN FFH
Citation: Ca. Uyldegroot et al., COST-EFFECTIVENESS AND QUALITY-OF-LIFE ASSESSMENT OF GM-CSF AS AN ADJUNCT TO INTENSIVE REMISSION INDUCTION CHEMOTHERAPY IN ELDERLY PATIENTSWITH ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 100(4), 1998, pp. 629-636
Authors:
UYLDEGROOT CA
VELLENGA E
DEVRIES EGE
LOWENBERG B
STOTER GJ
RUTTEN FFH
Citation: Ca. Uyldegroot et al., TREATMENT COSTS AND QUALITY-OF-LIFE WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH ANTINEOPLASTIC THERAPY-RELATED FEBRILE NEUTROPENIA - RESULTS OF A RANDOMIZED PLACEBO-CONTROLLED TRIAL, PharmacoEconomics, 12(3), 1997, pp. 351-360
Authors:
VANENCKEVORT PJ
KOOPMANSCHAP MA
TENVERGERT EM
GEERTSMA A
VANDERBIJ W
DEBOER WJ
RUTTEN FFH
Citation: Pj. Vanenckevort et al., LIFETIME COSTS OF LUNG TRANSPLANTATION - ESTIMATION OF INCREMENTAL COSTS, Health economics, 6(5), 1997, pp. 479-489
Authors:
BROUWER WBF
KOOPMANSCHAP MA
RUTTEN FFH
Citation: Wbf. Brouwer et al., PRODUCTIVITY COSTS IN COST-EFFECTIVENESS ANALYSIS - NUMERATOR OR DENOMINATOR - A FURTHER DISCUSSION, Health economics, 6(5), 1997, pp. 511-514
Authors:
BROUWER WBF
KOOPMANSCHAP MA
RUTTEN FFH
Citation: Wbf. Brouwer et al., PRODUCTIVITY COSTS MEASUREMENT THROUGH QUALITY-OF-LIFE - A RESPONSE TO THE RECOMMENDATION OF THE WASHINGTON PANEL, Health economics, 6(3), 1997, pp. 253-259
Authors:
GROENER MGH
VANINEVELD BM
BYTTEBIER G
RUTTEN FFH
Citation: Mgh. Groener et al., EVALUATION OF RELATIVE COSTS OF THE CYTOSTATIC AGENTS TOMUDEX(R) AND 5-FLUOROURACIL PLUS LEUCOVORIN AS TREATMENTS FOR ADVANCED COLORECTAL-CANCER, European journal of cancer, 33, 1997, pp. 11-11
Authors:
MICHEL BC
KUIJER PMM
MCDONNELL J
VANBEEK EJR
RUTTEN FFH
BULLER HR
Citation: Bc. Michel et al., THE ROLE OF A DECISION RULE IN SYMPTOMATIC PULMONARY-EMBOLISM PATIENTS WITH A NON-HIGH PROBABILITY VENTILATION-PERFUSION SCAN, Thrombosis and haemostasis, 78(2), 1997, pp. 794-798
Authors:
WIELINK G
ESSINKBOT ML
VANKERREBROECK PEV
RUTTEN FFH
Citation: G. Wielink et al., SACRAL RHIZOTOMIES AND ELECTRICAL BLADDER STIMULATION IN SPINAL-CORD INJURY .2. COST-EFFECTIVENESS AND QUALITY-OF-LIFE ANALYSIS, European urology, 31(4), 1997, pp. 441-446
Authors:
ELSINGA E
RUTTEN FFH
Citation: E. Elsinga et Ffh. Rutten, ECONOMIC-EVALUATION IN SUPPORT OF NATIONAL-HEALTH POLICY - THE CASE OF THE NETHERLANDS, Social science & medicine, 45(4), 1997, pp. 605-620
Authors:
KOOPMANSCHAP MA
RUTTEN FFH
VANINEVELD BM
VANROIJEN L
Citation: Ma. Koopmanschap et al., THE FRICTION COST METHOD - REPLY, Journal of health economics, 16(2), 1997, pp. 257-259
Authors:
VANDERRIET AAPM
VANHOUT BA
RUTTEN FFH
Citation: Aapm. Vanderriet et al., COST-EFFECTIVENESS OF DNA DIAGNOSIS FOR 4 MONOGENIC DISEASES, Journal of Medical Genetics, 34(9), 1997, pp. 741-745
Authors:
VANROIJEN L
NIJS HGT
AVEZAAT CJJ
KARLSSON G
LINQUIST C
PAUW KH
RUTTEN FFH
Citation: L. Vanroijen et al., COSTS AND EFFECTS OF MICROSURGERY VERSUS RADIOSURGERY IN TREATING ACOUSTIC NEUROMA, Acta neurochirurgica, 139(10), 1997, pp. 942-948
Authors:
KOOPMANSCHAP MA
RUTTEN FFH
Citation: Ma. Koopmanschap et Ffh. Rutten, A PRACTICAL GUIDE FOR CALCULATING INDIRECT COSTS OF DISEASE, PharmacoEconomics, 10(5), 1996, pp. 460-466
Authors:
AL MJ
MICHEL BC
RUTTEN FFH
Citation: Mj. Al et al., THE COST-EFFECTIVENESS OF DICLOFENAC PLUS MISOPROSTOL COMPARED WITH DICLOFENAC MONOTHERAPY IN PATIENTS WITH RHEUMATOID-ARTHRITIS, PharmacoEconomics, 10(2), 1996, pp. 141-151
COLONY-STIMULATING FACTORS AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - BENEFITS AND COSTS
Authors:
GROOT CAL
HUIJGENS PC
RUTTEN FFH
Citation: Cal. Groot et al., COLONY-STIMULATING FACTORS AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - BENEFITS AND COSTS, PharmacoEconomics, 10(1), 1996, pp. 23-35
Authors:
MICHEL BC
SEERDEN RJ
RUTTEN FFH
VANBEEK EJR
BULLER HR
Citation: Bc. Michel et al., THE COST-EFFECTIVENESS OF DIAGNOSTIC STRATEGIES IN PATIENTS WITH SUSPECTED PULMONARY-EMBOLISM, Health economics, 5(4), 1996, pp. 307-318
Authors:
DEGROOT CAU
VELLENGA E
RUTTEN FFH
Citation: Cau. Degroot et al., AN ECONOMIC-MODEL TO ASSESS THE SAVINGS FROM A CLINICAL-APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS, European journal of cancer, 32A(1), 1996, pp. 57-62
Authors:
VELLENGA E
UYLDEGROOT CA
DEWIT R
KEIZER HJ
LOWENBERG B
TENHAAFT MA
DEWITTE TJM
VERHAGEN CAH
STOTER GJ
RUTTEN FFH
MULDER NH
SMID WM
DEVRIES EGE
Citation: E. Vellenga et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH CHEMOTHERAPY-RELATED FEBRILE NEUTROPENIA, Journal of clinical oncology, 14(2), 1996, pp. 619-627